Logo image of CI

THE CIGNA GROUP (CI) Stock Overview

USA - NYSE:CI - US1255231003 - Common Stock

247.1 USD
-52.02 (-17.39%)
Last: 10/30/2025, 8:04:00 PM
248.3 USD
+1.2 (+0.49%)
Pre-Market: 10/31/2025, 7:01:44 AM

CI Key Statistics, Chart & Performance

Key Statistics
Market Cap65.96B
Revenue(TTM)247.12B
Net Income(TTM)5.02B
Shares266.93M
Float262.65M
52 Week High350
52 Week Low245.61
Yearly Dividend5.53
Dividend Yield2.02%
EPS(TTM)28.41
PE8.7
Fwd PE7.26
Earnings (Next)01-28 2026-01-28/amc
IPO1982-04-01
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services


CI short term performance overview.The bars show the price performance of CI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

CI long term performance overview.The bars show the price performance of CI in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20

The current stock price of CI is 247.1 USD. In the past month the price decreased by -16.8%. In the past year, price decreased by -21.92%.

THE CIGNA GROUP / CI Daily stock chart

CI Latest News, Press Relases and Analysis

CI Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CVS CVS HEALTH CORP 11.2 97.27B
LH LABCORP HOLDINGS INC 15.95 20.97B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 203.73 19.85B
DGX QUEST DIAGNOSTICS INC 18.01 19.65B
FMS FRESENIUS MEDICAL CARE-ADR 13.27 15.66B
GH GUARDANT HEALTH INC N/A 11.52B
HIMS HIMS & HERS HEALTH INC 55.08 9.96B
DVA DAVITA INC 12.24 8.49B
CHE CHEMED CORP 20.66 6.62B
RDNT RADNET INC 211.39 5.85B
BTSG BRIGHTSPRING HEALTH SERVICES 59.62 5.81B
OPCH OPTION CARE HEALTH INC 17.59 4.25B

About CI

Company Profile

CI logo image The Cigna Group is a global health company, which engages in the provision of global health services. The company is headquartered in Bloomfield, Connecticut and currently employs 73,500 full-time employees. The firm has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.

Company Info

THE CIGNA GROUP

900 Cottage Grove Road

Bloomfield CONNECTICUT 06002 US

CEO: David M. Cordani

Employees: 73500

CI Company Website

CI Investor Relations

Phone: 18602266000

THE CIGNA GROUP / CI FAQ

What does CI do?

The Cigna Group is a global health company, which engages in the provision of global health services. The company is headquartered in Bloomfield, Connecticut and currently employs 73,500 full-time employees. The firm has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.


What is the current price of CI stock?

The current stock price of CI is 247.1 USD. The price decreased by -17.39% in the last trading session.


Does THE CIGNA GROUP pay dividends?

THE CIGNA GROUP (CI) has a dividend yield of 2.02%. The yearly dividend amount is currently 5.53.


What is the ChartMill rating of THE CIGNA GROUP stock?

CI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the analyst forecast for CI stock?

34 analysts have analysed CI and the average price target is 368.65 USD. This implies a price increase of 49.19% is expected in the next year compared to the current price of 247.1.


Is THE CIGNA GROUP (CI) expected to grow?

The Revenue of THE CIGNA GROUP (CI) is expected to grow by 9.32% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


How many employees does THE CIGNA GROUP have?

THE CIGNA GROUP (CI) currently has 73500 employees.


CI Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to CI. When comparing the yearly performance of all stocks, CI is a bad performer in the overall market: 84.29% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CI. There are concerns on the financial health of CI while its profitability can be described as average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CI Financial Highlights

Over the last trailing twelve months CI reported a non-GAAP Earnings per Share(EPS) of 28.41. The EPS increased by 3.35% compared to the year before.


Industry RankSector Rank
PM (TTM) 1.92%
ROA 3.31%
ROE 12.48%
Debt/Equity 0.66
Chartmill High Growth Momentum
EPS Q2Q%4.26%
Sales Q2Q%9.22%
EPS 1Y (TTM)3.35%
Revenue 1Y (TTM)26.56%

CI Forecast & Estimates

34 analysts have analysed CI and the average price target is 368.65 USD. This implies a price increase of 49.19% is expected in the next year compared to the current price of 247.1.

For the next year, analysts expect an EPS growth of 11.61% and a revenue growth 9.32% for CI


Analysts
Analysts81.18
Price Target368.65 (49.19%)
EPS Next Y11.61%
Revenue Next Year9.32%

CI Ownership

Ownership
Inst Owners90.02%
Ins Owners0.34%
Short Float %1.44%
Short Ratio2.6